Squarepoint’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.63M | Buy |
572,548
+420,398
| +276% | +$3.4M | ﹤0.01% | 820 |
|
|
2025
Q1 | $1.28M | Buy |
152,150
+27,406
| +22% | +$230K | ﹤0.01% | 1386 |
|
|
2024
Q4 | $988K | Buy |
124,744
+105,268
| +541% | +$834K | ﹤0.01% | 1543 |
|
|
2024
Q3 | $162K | Sell |
19,476
-91,798
| -82% | -$764K | ﹤0.01% | 2238 |
|
|
2024
Q2 | $707K | Buy |
+111,274
| New | +$707K | ﹤0.01% | 1547 |
|
|
2023
Q4 | – | Sell |
-31,020
| Closed | -$131K | – | 2480 |
|
|
2023
Q3 | $131K | Buy |
+31,020
| New | +$131K | ﹤0.01% | 2213 |
|
|
2023
Q2 | – | Sell |
-84,308
| Closed | -$117K | – | 2372 |
|
|
2023
Q1 | $117K | Buy |
84,308
+61,251
| +266% | +$85.1K | ﹤0.01% | 1997 |
|
|
2022
Q4 | $45.9K | Buy |
+23,057
| New | +$45.9K | ﹤0.01% | 2155 |
|
|
2022
Q3 | – | Sell |
-55,303
| Closed | -$176K | – | 2053 |
|
|
2022
Q2 | $176K | Sell |
55,303
-35,305
| -39% | -$112K | ﹤0.01% | 1771 |
|
|
2022
Q1 | $378K | Buy |
90,608
+38,321
| +73% | +$160K | ﹤0.01% | 1625 |
|
|
2021
Q4 | $250K | Sell |
52,287
-3,039
| -5% | -$14.5K | ﹤0.01% | 1962 |
|
|
2021
Q3 | $295K | Sell |
55,326
-19,273
| -26% | -$103K | ﹤0.01% | 1642 |
|
|
2021
Q2 | $382K | Buy |
+74,599
| New | +$382K | ﹤0.01% | 1790 |
|
|
2021
Q1 | – | Sell |
-93,034
| Closed | -$425K | – | 2526 |
|
|
2020
Q4 | $425K | Sell |
93,034
-70,723
| -43% | -$323K | ﹤0.01% | 1607 |
|
|
2020
Q3 | $635K | Buy |
163,757
+152,027
| +1,296% | +$590K | 0.01% | 1174 |
|
|
2020
Q2 | $56K | Sell |
11,730
-26,707
| -69% | -$128K | ﹤0.01% | 2015 |
|
|
2020
Q1 | $134K | Sell |
38,437
-364,471
| -90% | -$1.27M | ﹤0.01% | 1577 |
|
|
2019
Q4 | $1.94M | Sell |
402,908
-7,095
| -2% | -$34.2K | 0.01% | 905 |
|
|
2019
Q3 | $1.19M | Buy |
+410,003
| New | +$1.19M | 0.01% | 1083 |
|
|
2019
Q2 | – | Sell |
-286,808
| Closed | -$4.06M | – | 2268 |
|
|
2019
Q1 | $4.06M | Buy |
286,808
+216,251
| +306% | +$3.06M | 0.04% | 519 |
|
|
2018
Q4 | $955K | Buy |
+70,557
| New | +$955K | 0.01% | 925 |
|